Gate2Brain is a biotech company to improve drug delivery with peptide-based patented technology.
Gate2Brain has raised $8.1M in total funding. The most recent round was Corporate Round. The last funding was announced in June 2026.
Gate2Brain's investors include European Innovation Council, BStartup - Banc Sabadell, Shilpa Biocare.
Gate2Brain is headquartered in Barcelona, Spain.
Gate2Brain is a biotech company to improve drug delivery with peptide-based patented technology.
Gate2Brain is at the Corporate Round stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Gate2Brain — Funding & Investors." VCBacked, June 8, 2026, https://www.vcbacked.co/company/gate2brain. Accessed July 20, 2026.
VCBacked. (2026). Gate2Brain — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/gate2brain
{{cite web |title=Gate2Brain — Funding & Investors |url=https://www.vcbacked.co/company/gate2brain |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated